$62.00
A single-chain relaxin analogue studied for anti-fibrotic activity and tissue remodelling research.
B7-33 is a single-chain peptide analogue of relaxin-2 designed to selectively activate the RXFP1 receptor through biased signalling that avoids cAMP elevation. Research has explored B7-33 as a potential anti-fibrotic agent, with studies suggesting it may reduce collagen deposition and support tissue remodelling in fibrotic disease models. Nexopep supplies B7-33 6mg as a lyophilised research compound independently tested for purity. For in-vitro research use only.
Reviews
There are no reviews yet.